Core Scientific Inc vs Erasca Inc. Common Stock — how do they compare? Core Scientific Inc trades at $15.21 (market cap $4.94B), while Erasca Inc. Common Stock trades at $16.07 (market cap $5.40B). The key difference: Core Scientific Inc and Erasca Inc. Common Stock are close in size by market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Erasca Inc. Common Stock for 0 Days on average.
| CORZ | ERAS | |
|---|---|---|
Market Cap | $4.94B | $5.40B |
Volume | 15,630,800 | 9,533,185 |
Sector | Technology | Health |
52-Week High | $29.16 | $22.47 |
52-Week Low | $13.57 | $2.20 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $7.46B | $5.18B |
Signals from Pluang's Aura AI — not financial advice
CORZ trades at $15.25, down 4.36% today amid a bearish technical trend. The stock shows weak fundamentals with a net loss of $288.62 million in 2025 and negative profit margins, though revenue is projected to grow to $440 million in 2026. Analyst sentiment remains strongly bullish with an 86% buy rating and a $32.75 consensus price target, but recent earnings misses and high cash burn pose significant risks.
The outlook is mixed: strong analyst support and insider buying suggest confidence in the AI data center strategy, but persistent losses, negative cash flow, and competitive pressures require careful monitoring. The stock's current price near support levels offers potential upside if execution improves, yet volatility and operational challenges present substantial downside risk.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →